Results 81 to 90 of about 17,345 (219)

Miraculin Can Contribute to a Reduction in Inflammatory Biomarkers and Cachexia in Malnourished Patients with Cancer and Taste Disorders

Pharmaceuticals
Background: In 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The number of new cancer cases is expected to rise to over 35 million by 2050, marking a 75% increase from 2022 levels.
Ana Isabel Álvarez-Mercado, Bricia López-Plaza, Julio Plaza-Diaz, Lucía Arcos-Castellanos, Francisco Javier Ruiz-Ojeda, Marco Brandimonte-Hernández, Jaime Feliú-Batlle, Thomas Hummel, Samara Palma-Milla, Ángel Gil   +9 more
doaj   +1 more source

Family Impact of Burning Mouth Syndrome: A Cross‐Sectional Study Using FROM‐16

Oral Diseases, EarlyView.
ABSTRACT Background Burning mouth syndrome (BMS) is a chronic oral pain condition associated with psychological distress and reduced quality of life. Although BMS' impact on patients is documented, family member impact remains poorly understood. This study evaluated family impact using Family Reported Outcome Measure (FROM‐16), explored family burden ...
Mona Jullie Hajj, Nicholas Sotak, Alessandro Villa, Alan Roger Santos‐Silva, Lloyd Mancl, Thaís Cristina Esteves‐Pereira, Milda Chmieliauskaite   +6 more
wiley   +1 more source

A Comparative Study on the General and Otolaryngological Manifestations of COVID-19 in the Hospitalized Population of the Telangana Region During the First and Second Waves

International Archives of Otorhinolaryngology
Introduction Some common symptoms of coronavirus disease 2019 (COVID-19) are fever, cough, and shortness of breath. But ear, nose, and throat (ENT) manifestations such as loss of smell and taste are also very common.
Uma Pokala, Shilpa Potnuru, Sasikala Kanapalli, Agni Vishnu Sailesh, Naveen P.   +4 more
doaj   +1 more source

Disproportionality analysis of taste disorders using the FDA adverse event reporting system and Japanese adverse drug event report databases

Frontiers in Pharmacology
IntroductionTaste disorders, which can diminish the quality of life and potentially affect drug treatment efficacy, are adverse events that may occur with the use of various medications; however, only a few studies have comprehensively examined this ...
Yoji Kyotani, Kiichi Nakahira, Masanori Yoshizumi   +2 more
doaj   +1 more source

Validation of the Hamilton Anxiety and Depression Rating Scales in Oral Lichen Planus: A Multicenter Study by the Italian Society of Oral Pathology and Medicine

Oral Diseases, EarlyView.
ABSTRACT Objective To assess the psychometric performance of the Hamilton Anxiety Rating Scale (HAM‐A) and Hamilton Depression Rating Scale (HAM‐D) in patients with oral lichen planus (OLP) according to clinical phenotype. Methods This multicenter SIPMO case–control study included 395 participants: 132 patients with keratotic OLP (K‐OLP), 131 with non ...
Daniela Adamo, Gennaro Musella, Federica Canfora, Elena Calabria, Simone Liguori, Carlo Lajolo, Gioele Gioco, Giulia Ottaviani, Katia Rupel, Matteo Biasotto, Margherita Gobbo, Maddalena Manfredi, Paolo Vescovi, Amerigo Giudice, Cristina D'Antonio, Paolo Arduino, Alessio Gambino, Monica Pentenero, Olga Anna Furchì, Davide Bartolomeo Gissi, Andrea Gabusi, Lorenzo Azzi, Angelo Tagliabue, Gianluca Tenore, Andrea Santarelli, Andrea Sardella, Elena M. Varoni, Giovanni Lodi, Giuseppina Campisi, Vera Panzarella, Michele Giuliani, Lorenzo Lo Muzio, Massimo Aria, Luca D'Aniello, Michele Davide Mignogna, Umberto Romeo, SIPMO (Italian Society of Oral Pathology and Medicine)   +36 more
wiley   +1 more source

Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy

, 2016
Dysgeusia is a significant factor reducing quality of life and worsening dysphagia in patients receiving chemoradiation therapy for head and neck cancer. The factors affecting dysgeusia severity are uncertain.
El Naqa, Issam, Feng, Felix, Samuels, Stuart, Murdoch-Kinch, Carol A, Feng, Mary, Eisbruch, Avraham, Schipper, Matthew, Tao, Yebin, Sapir, Eli   +8 more
core   +1 more source

UK Medical Cannabis Registry: A Two‐Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia

Neuropsychopharmacology Reports, Volume 46, Issue 4, December 2026.
Insomnia affects around one in ten adults. In this 2‐year UK Medical Cannabis Registry cohort study of 211 adults with insomnia, treatment with cannabis‐based medicinal products was associated with a sustained improvement in self‐reported sleep quality across 24 months.
Aran Koye, Simon Erridge, Evonne Clarke, Katy McLachlan, Ross Coomber, James J. Rucker, Mark W. Weatherall, Mikael H. Sodergren   +7 more
wiley   +1 more source

Improvement of Dysgeusia after Thymectomy with Thymoma.

The Kurume Medical Journal, 1999
We present a case of 39-year-old woman with thymoma complaining of dysgeusia. This patient had suffered from dysgeusia for the previous 6 months. Thymectomy with the thymoma was performed, and her dysgeusia was improved within 6 months after the operation. The anti-acetylcholine-receptor antibody was reduced from 0.9 nmol/l to 0.4 nmol/l (normal: below
TAKAMORI, SHINZO, HAYASHI, AKIHIRO, TAYAMA, KOHSUKE, MITSUOKA, MASAHIRO, TANIGAWA, HIROKAZU, TAMURA, KOICHI, SHIROUZU, KAZUO   +6 more
openaire   +3 more sources

Zinc Gluconate in the Treatment of Dysgeusia—a Randomized Clinical Trial [PDF]

, 2013
In the treatment of dysgeusia, the use of zinc has been frequently tried, with equivocal results. The aim of the present randomized clinical trial, which involved a sufficiently large sample, was therefore to determine the efficacy of zinc treatment ...
Heckmann, Siegfried Martin, Friess, W., Wichmann, Manfred, Hummel, T., Heckmann, Josef G., Hujoel, P., Habiger, S.   +6 more
core  

Development and Validation of Dysgeusia Grading Scale for Patients with Head and Neck Cancers Treated with Intensity-Modulated Radiation Therapy: A Research Protocol

, 2021
Head and neck cancer patients present with dysgeusia despite the advent of modern radiotherapy techniques. However, there is currently no tool that can be used to evaluate taste alteration in patients undergoing radiotherapy.
Michael Benedict A. Mejia, Mark Pascual Dumago, Kelvin Ken L. Yu, Janine Margarita R. Dizon, John Rey B. Macindo, Warren R. Bacorro, Eugene T. Yap, Luisa E. Jacomina   +7 more
core   +1 more source